The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO GI 2021 | Immuno-oncology in MSI colorectal cancer

Name: Immuno-oncology in MSI colorectal cancer
Uploaded: 2021-01-20T00:00:00Z
Duration: 1 min 38 s
Description: Thierry André, MD, Hospital Saint Antoine, Paris, France, outlines advances in the use of immunotherapy in patients with microsatellite instable (MSI) colorectal cancer, and future approaches in this field. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Thierry André • 20 Jan 2021

ASCO GI 2021

Colorectal Cancer Gastrointestinal Cancer

Thierry André, MD, Hospital Saint Antoine, Paris, France, outlines advances in the use of immunotherapy in patients with microsatellite instable (MSI) colorectal cancer, and future approaches in this field. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).